James Kihara - Net Worth and Insider Trading
James Kihara Net Worth
The estimated net worth of James Kihara is at least $345,020 dollars as of 2024-12-26. James Kihara is the PRINCIPAL ACCOUNTING OFFICER of ACADIA Pharmaceuticals Inc and owns about 19,863 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $345,020. Details can be seen in James Kihara's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Kihara has not made any transactions after 2024-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Kihara
James Kihara Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Kihara owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of James Kihara’s form 4 insider trades.
Insider Ownership Summary of James Kihara
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-11-19 | Principal Accounting Officer |
James Kihara Latest Holdings Summary
James Kihara currently owns a total of 1 stock. James Kihara owns 19,863 shares of ACADIA Pharmaceuticals Inc (ACAD) as of November 19, 2024, with a value of $345,020.
Latest Holdings of James Kihara
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-11-19 | 19,863 | 17.37 | 345,020 |
Holding Weightings of James Kihara
James Kihara Form 4 Trading Tracker
According to the SEC Form 4 filings, James Kihara has made a total of 14 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 4,073 shares on November 19, 2024, which brought James Kihara around $68,467.
Insider Trading History of James Kihara
- 1
James Kihara Trading Performance
James Kihara Ownership Network
James Kihara Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
James Kihara is the Principal Accounting Officer of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, James Kihara made 7 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 13,648. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 319,936 shares made by Stephen Davis , a net sale of 48,500 shares made by Mark C. Schneyer , and a net sale of 37,363 shares made by Brendan Teehan .
In summary, during the past 3 months, insiders sold 24,661 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 24,661 shares. During the past 18 months, 436,406 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 436,406 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
James Kihara Mailing Address
Above is the net worth, insider trading, and ownership report for James Kihara. You might contact James Kihara via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
